GlassScriptPhysician profile
Benjamin Ray Wilson
NPI 1871900068
$9,087.41
in general payments reported to CMS, 2019-2025
10 companies · $46.84 in 2025
The $46.84 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,712 · 2020: $3,333 · 2021: $1,313 · 2022: $73.01 · 2024: $609 · 2025: $46.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,053.80 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Spatial Frame, Acufex Trunav |
| Pylant Medical | $1,229.85 | 2021 | |
| Medical Device Business Services, INC. | $318.99 | 2019 | |
| Stryker Corporation | $205.26 | 2024 | Alphavent |
| Heron Therapeutics, INC. | $83.33 | 2021 | |
| Xiros INC | $73.01 | 2022 | |
| Wright Medical Technology, INC. | $43.38 | 2019 | |
| Pinnacle Biologics, INC | $24.51 | 2025 | Photofrin |
| Glaxosmithkline, LLC. | $22.33 | 2025 | Jemperli |
| Depuy Synthes Sales INC. | $16.96 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.